Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Melatonin for Radiotherapy-Induced Fatigue in Breast Cancer
NCT07865988Phase 3Completed
- Sponsor
- Menoufia University
- Start
- Oct 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Melatonin Group with Placebo Group (2 arms). Primary endpoint: Piper Fatigue Scale. Started Oct 2024; status: completed.
02
Drugs
melatonin
Beyond the preview
Go deeper on NCT07865988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07865988.